ISSN: 1524-9557

Journal Home

Journal Guideline

Journal of immunotherapy (Hagerstown, Md. : 1997) Q1 Unclaimed

Lippincott Williams and Wilkins Ltd. United States

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Journal of immunotherapy (Hagerstown, Md. : 1997) is a journal indexed in SJR in Pharmacology and Immunology with an H index of 106. It has an SJR impact factor of 1,263 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 1,263.

Journal of immunotherapy (Hagerstown, Md. : 1997) focuses its scope in these topics and keywords: cd, monoclonal, cells, tcell, cell, antibody, oncogene, patients, specific, dendritic, ...

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy:

Type of publications:

Publication frecuency: -

Categories: Pharmacology (Q1) Cancer Research (Q2) Immunology (Q2) Immunology and Allergy (Q2) Immunology and Allergy (Q2)

Price

- €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

Journal of immunotherapy (Hagerstown, Md. : 1997)

1,263

SJR Impact factor

106

H Index

44

Total Docs (Last Year)

150

Total Docs (3 years)

1376

Total Refs

521

Total Cites (3 years)

149

Citable Docs (3 years)

3.12

Cites/Doc (2 years)

31.27

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Pharmacological Reviews Q1
Drug Resistance Updates Q1
Annual Review of Pharmacology and Toxicology Q1
Molecular Therapy Q1
Journal for ImmunoTherapy of Cancer Q1

Compare this journals

Aims and Scope

Best articles by citations

Humanization of Antagonistic Anti-Human 4-1BB Monoclonal Antibody Using a Phage-Displayed Combinatorial Library

Specific Release of Cytokines by Lymphocytes Infiltrating Human Melanomas in Response to Shared Melanoma Antigens

Combination Human B7.1/NHS76 and B7.1/Fc Fusion Protein Immunotherapy and CD25+ T-Regulatory Cell Depletion Produces Complete Remissioin of Transplanted Solid Tumors

Ex Vivo Activated Immune Cells Promote Survival and Stimulate Multilineage Hematopoietic Recovery in Myelosuppressed Mice

Immunoselection of Functional CMRF-56+ Blood Dendritic Cells from Multiple Myeloma Patients for Immunotherapy

Cytokines Delivered by Biodegradable Microspheres Promote Effective Suppression of Human Tumors by Human Peripheral Blood Lymphocytes in the SCID-Winn Model

NK Cells Mediate Flt3 Ligand-Induced Protection of Dendritic Cell Precursors In Vivo from the Inhibition by Prostate Carcinoma in the Murine Bone Marrow Metastasis Model

Immunological Monitoring of Patients with Melanoma After Peptide Vaccination Using Soluble Peptide/HLA-A2 Dimer Complexes

Inhibiting of Inflammatory Mediators

Generating Potent Th1/Tc1 T Cell Adoptive Immunotherapy Doses Using Human IL-12: Harnessing the Immunomodulatory Potential of IL-12 Without the In Vivo-Associated Toxicity

Cytokines-Polymorphisms

Report from the Society for Biological Therapy and Vascular Biology Faculty of the NCI Workshop on Angiogenesis Monitoring

SHOW MORE ARTICLES

Carbonic Anyhydrase IX (CAIX) Expression Does Not Correlate with the Renal Cell Cancer (RCC) Patient Response to CCI-779

Enhanced Tumor Inhibition of MDA-MB-231 Breast Carcinoma by the Anti-Tissue Factor Antibody, CNTO 860, Is Mediated by Antibody Dependent Cellular Cytotoxicity

Inflammatory Myopathy and Axonal Neuropathy in a Patient With Melanoma Following Pembrolizumab Treatment

Genomics

ATP and HMGB1 Act as Endogenous Danger Signals in Cancer

Adoptive Immunotherapy

Adoptive Immunotherapy of Cancer with Polyclonal Hyperexpanded CD4 and CD8 T Cells Derived from Tumor-Draining Lymph Nodes

Correlation between Pulmonary Edema and Response of Pulmonary Metastases to High Dose Continuous Infusion Interleukin-2 in Metastatic Melanoma and Kidney Cancer

Adoptive Transfer From Interferon-a-Fed Mice Is Associated With Inhibition of Active Experimental Autoimmune Encephalomyelitis by Decreasing Recipient Tumor Necrosis Factor-a Secretion

Adoptive Transfer of Anti-idiotypic T Cells Cure Mice of Disseminated B Cell Lymphoma

Adoptive Transfer of Cloned Melanoma-Reactive T Lymphocytes for the Treatment of Patients with Metastatic Melanoma

Generation of Rituximab Polymer and Evaluation of CD20 Hyper-Crosslinking-Induced Apoptosis in Non-Hodgkin's Lymphomas